Hereditary transthyretin amyloidosis, once a rare progressive neuropathy and/or
cardiomyopathy, is now recognized with increasing worldwide frequency, various …

Background Hereditary transthyretin amyloidosis is an uncommon multisystem disorder
caused by mutation of the transthyretin protein, leading to peripheral neuropathy often with …

Objectives: Describe atypical presentations of hereditary transthyretin-mediated (hATTR)
amyloidosis with polyneuropathy. Methods: Initial symptoms, diagnoses, and follow-up were …

Hereditary transthyretin amyloidosis: current treatment : Current Opinion in Neurology
Hereditary transthyretin amyloidosis: current treatment : Current Opinion in Neurology Log in or …

Transthyretin amyloidosis is a progressive and eventually fatal disease primarily
characterized by sensory, motor, and autonomic neuropathy and/or cardiomyopathy. Given …

Transthyretin amyloidosis (ATTR) is either a hereditary disease related to a mutation in the
transthyretin gene that leads to neuropathy and/or cardiomyopathy or an acquired disease …

Hereditary transthyretin-mediated amyloidosis is a rapidly progressive, heterogeneous
disease caused by the accumulation of misfolded transthyretin protein as amyloid fibrils at …

Hereditary transthyretin amyloidosis is described in this review, including the TTR gene
structure and mutation spectrum, the transthyretin protein structure and functions, the main …

Over the last decade, new medical treatment modalities have emerged based on increased
insights into amyloid formation. With the increased possibilities for treatment of amyloidosis …

Introduction Although peripheral neuropathy and cardiomyopathy are well‐recognized
manifestations of transthyretin (ATTR) amyloidosis, myopathy has been rarely reported …